P. R. Kanani and A. Pillai, “A comparative study of effectiveness, safety and cost effectiveness of olanzapine, risperidone and aripiprazole therapy in schizophrenia”, Int J Basic Clin Pharmacol, vol. 9, no. 5, pp. 786–791, Apr. 2020.